CoChat

Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery

Open access
Lee, Jeeyun, Sohn, Insuk, Do, In-Gu, Kim, Kyoung-Mee, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Sohn, Tae Sung, Bae, Jae Moon, Choi, Min Gew, Lim, Do Hoon, Min, Byung Hoon, Lee, Joon Haeng, Rhee, Poong Lyul, Kim, Jae J., Choi, Dong Il, Tan, Iain Beehuat, Das, Kakoli, Tan, Patrick, Jung, Sin Ho, Kang, Won Ki, Kim, Sung · 2014 · PLoS ONE
Cited by 141

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Despite the benefits from adjuvant chemotherapy or chemoradiotherapy, approximately one-third of stage II gastric cancer (GC) patients developed recurrences. The aim of this study was to develop and validate a prognostic algorithm for gastric cancer (GCPS) that can robustly identify high-risk group for recurrence among stage II patients. A multi-step gene expression profiling study was conducted. First, a microarray gene expression profiling of archived paraffin-embedded tumor blocks was used to identify candidate prognostic genes (N=432). Second, a focused gene expression assay including prognostic genes was used to develop a robust clinical assay (GCPS) in stage II patients from the same cohort (N=186). Third, a predefined cut off for the GCPS was validated using an independent stage II cohort (N=216). The GCPS was validated in another set with stage II GC who underwent surgery without adjuvant treatment (N=300). GCPS was developed by summing the product of Cox regression coefficients and normalized expression levels of 8 genes (LAMP5, CDC25B, CDK1, CLIP4, LTB4R2, MATN3, NOX4, TFDP1). A prospectively defined cut-point for GCPS classified 22.7% of validation cohort treated with chemoradiotherapy (N=216) as high-risk group with 5-year recurrence rate of 58.6% compared to 85.4% in the low risk group (hazard ratio for recurrence=3.16, p=0.00004). GCPS also identified high-risk group among stage II patients treated with surgery only (hazard ratio=1.77, p=0.0053).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0090133

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

  • Direct multiplexed measurement of gene expression with color-coded probe pairs

    Geiss, G. K., Bumgarner, R. E., Birditt, B., Dahl, T., Dowidar, N., Dunaway, D. L., Fell, H. P., Ferree, S., George, R. D., Grogan, T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1385 · Cited by 2,066 · cited 1×

    “For nCounter assay, 200 ng of total RNA was hybridized with the custom designed code set of 800 genes for 18 hours at 65uC and processed according to manufacturer’s instruction [12].”
    Method

Show all 1 references

Cited by

See all 141

Metadata

Authors
Lee, J., Sohn, I., Do, I.-G., Kim, K.-M., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Sohn, T. S., Bae, J. M., Choi, M. G., Lim, D. H., Min, B. H., Lee, J. H., Rhee, P. L., Kim, J. J., Choi, D. I., Tan, I. B., Das, K., Tan, P., Jung, S. H., Kang, W. K., & Kim, S.
Venue
PLoS ONE
Published
2014-03-05
Volume
9
Issue
3
Pages
e90133
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2015162631
Cited by
141
References
1
FWCI
8.24
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery. https://app.cochat.ai/papers/10.1371/journal.pone.0090133
The paper
Lee, J., Sohn, I., Do, I.-G., Kim, K.-M., Park, S. H., Park, J. O., Park, Y. S., Lim, H. Y., Sohn, T. S., Bae, J. M., Choi, M. G., Lim, D. H., Min, B. H., Lee, J. H., Rhee, P. L., Kim, J. J., Choi, D. I., Tan, I. B., Das, K., . . . Kim, S. (2014). Nanostring-Based Multigene Assay to Predict Recurrence for Gastric Cancer Patients after Surgery. PLoS ONE. https://doi.org/10.1371/journal.pone.0090133

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.